Drug Shortage Report for NUCYNTA EXTENDED-RELEASE
| Report ID | 205952 |
| Drug Identification Number | 02415607 |
| Brand name | NUCYNTA EXTENDED-RELEASE |
| Common or Proper name | TAPENTADOL |
| Company Name | ENDO OPERATIONS LTD. |
| Market Status | MARKETED |
| Active Ingredient(s) | TAPENTADOL |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 60 tabs |
| ATC code | N02AX |
| ATC description | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-09-22 |
| Estimated end date | 2024-07-15 |
| Actual end date | 2024-07-10 |
| Shortage status | Resolved |
| Updated date | 2025-10-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.